黄芪-丹参药对通过下调miR-466b-5p改善高血压肾损害
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金面上项目(81673812)


Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma Herbal Pair Reduces Hypertensive Renal Damage by Down-regulating MiR-466b-5p
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨黄芪-丹参药对通过调节微小核糖核酸-466b-5P(miR-466b-5p)改善高血压肾损害的机制。方法:基于微RNA(miRNA)测序寻找自发性高血压大鼠与Wistar-京都鼠(WKY)的差异基因,构建腺相关病毒转染小鼠,24只C57BL/6小鼠,随机选取12只尾静脉注射小鼠腺相关病毒miR-466b-5P(rAAV-miR-466b-5P)构建miR-466b-5p过表达组,余12只作为空白对照组注射腺相关病毒-9(AAV-9)空载体,转染6周后再各随机分为2组,每组6只,A组(黄芪-丹参+miR-466b-5P过表达组)和C组(黄芪-丹参+空白对照组)以黄芪配方颗粒:2.036 g/kg+丹参配方颗粒:0.255 g/kg灌胃;B组(miR-466b-5P过表达组)和D组(空白对照组)以相同体积生理盐水灌胃;灌胃28 d后观察各组小鼠尿β2-微球蛋白(β2-MG)、N-乙酰-β-D-葡萄糖苷酶(NAG)、微量白蛋白(mALB),血清胱抑素C(Cys-C)、血管紧张素Ⅱ(AngⅡ)、C反应蛋白(CRP)水平和肾脏病理,进行实时荧光定量(RT-qPCR)与蛋白质印迹法(Western Blotting)寻找其靶基因。结果:1)基于前期miRNA测序选定了miR-466b-5p;2)与D组比较,B组小鼠尿β2-MG、NAG、mALB、血清Cys-C、AngⅡ、CRP均显著升高(P<0.01);与B组比较,A组小鼠血清Cys-C、CRP明显升高(P<0.05),尿β2-MG、NAG、mALB、血清AngⅡ无明显改变(P>0.05);3)与D组比较,B组小鼠出现明显肾小球硬化、小管纤维化,A组较B组有明显改善;4)与D组比较,B组小鼠透明质酸酶2(HAS2)明显下调,而经黄芪-丹参干预后有所回调。结论:miR-466b-5p的过表达会导致高血压肾损害的发生,黄芪-丹参药对通过靶向HAS2下调miR-466b-5p改善高血压肾损害。

    Abstract:

    To explore the mechanism of Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma herbal pair in reducing hypertensive renal damage by regulating miR-466b-5p.Methods:The differential genes between spontaneously hypertensive rats(SHR) and Wistar-Kyoto(WKY) rats were found by miRNA sequencing to construct adeno-associated virus-transfected rats.Twelve out of 24 C57BL/6 mice were randomly selected to be injected with adeno-associated virus miR-466b-5P(rAAV-miR-466b-5P) into the tail vein to construct a miR-466b-5p overexpression group,and the other 12 mice were assigned to the blank control group and were injected with AAV-9 empty carrier.Six weeks after the transfection,the two groups were randomly subdivided into two groups,with six mice in each group.Group A(Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma+miR-466b-5P overexpression group) and group C(Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma+blank control group) received Huangqi Formula Granules(2.036 g/kg) and Danshen Formula Granules(0.255 g/kg) by gavage.Group B(miR-466b-5P overexpression group) and group D(blank control group) were received the same volume of saline by gavage.After 28 d of intragastric administration,the urine β2-microglobulin(β2-MG),N-acetyl-β-D-glucosidase(NAG),microalbumin(mALB),serum cystatin C(Cys-C),angiotensin Ⅱ(AngⅡ),and C-reactive protein(CRP) levels and renal pathology of mice were observed in each group,and Real-time fluorescence quantitative polymerase chain reaction(RT-qPCR) and Western Blotting assay were performed to find the target genes.Results:1) MiR-466b-5p was selected based on previous miRNA sequencing. 2) The urine β2-MG,NAG,mALB,serum Cys-C,AngⅡ,and CRP levels in group B were higher than those in the group D(P<0.01).Compared with the results in group B,the serum Cys-C and CRP levels increased in group A(P<0.01),while the urine β2-MG,NAG,mALB,and serum AngⅡ levels did not change significantly(P>0.05). 3) Compared with group D,group B showed significant glomerulosclerosis and tubular fibrosis,and group A showed significant improvement compared with group B. 4) The hyaluronidase 2(HAS2) was significantly down-regulated in group B,which was reversed after Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma intervention as compared with that in the group D.Conclusion:The overexpression of miR-466b-5p can cause hypertensive renal damage,and Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma can down-regulate miR-466b-5p by targeting HAS2 to reduce hypertensive renal damage.

    参考文献
    相似文献
    引证文献
引用本文

李祥宇,崔涛,姜月华,李伟.黄芪-丹参药对通过下调miR-466b-5p改善高血压肾损害[J].世界中医药,2023,(05).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-02-07
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-05-01
  • 出版日期:
文章二维码